BetterLife Pharma Inc.
BETRF · OTC
1/31/2025 | 1/31/2024 | 1/31/2023 | 1/31/2022 | |
|---|---|---|---|---|
| Market Cap | $16 | $8 | $13 | $16 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $1 | $1 | $1 | $1 |
| Enterprise Value | $17 | $10 | $14 | $17 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | $0 | -$3 | -$9 | -$12 |
| % Margin | – | – | – | – |
| Net Income | -$4 | -$3 | -$9 | -$12 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.028 | -0.026 | -0.1 | -0.16 |
| % Growth | -7.6% | 73.6% | 37.5% | – |
| Operating Cash Flow | -$2 | -$2 | -$2 | -$11 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$2 | -$2 | -$2 | -$11 |